Floridienne S.A.

Earnings Release • May 19, 2014

Press Release – Regulated Information – Embargo 19 May 2014, 6 pm

Floridienne Group: Interim Statement

1. Situation and outlook

With no impact from 5N Plus and Floridienne Chimie, the first quarter of 2014 shows a strong improvement compared to that of 2013. Excluding the exceptional items from 2013, the results of Floridienne Group's recurring activities are also making headway compared to the first quarter of 2013.

The Chemical Division, separated from Floridienne Chimie, has shown good progress in its activities overall. Sales of stabilisers in Eastern Europe (IKA) and Turkey (Kimflor) were sustained during this quarter. SNAM's results also showed strong progress during the first quarter, thanks to the various measures successfully taken in 2013 to improve this company's profitability, as well as an increase in nickel prices in March.

The Food Division continued its growth in its various markets in the first quarter, and its results are in line with forecasts. The Life Sciences Division is also in line with its budget. Both Enzymes and Biobest, despite being affected by the bankruptcy of a major client, posted performances that show an increase on last year.

With regard to 5N Plus, Floridienne Group had a remaining debt of €1.75 million from this company, which fell due on 9 April 2014. This debt was paid on its due date, so Floridienne Group no longer has any exposure to the Canadian group 5N Plus. Based on the current outlook for all of the Group's activities, Floridienne's Management Board maintains its targets for positive recurrent results for the Group's three Divisions in 2014.

2. Financial Calendar

Ordinary General Meeting	3 June 2014
Half-yearly results	end of August 2014
2nd interim statement	19 November 2014

Philippe Bodson, Chairman Gaëtan Waucquez, Managing Director

Contact: Tel.: +32 2 353 00 28

FLORIDIENNE is a Belgian industrial group listed on the Brussels Euronext Stock Exchange which is the European-leader or world-leader in a number of market niches and niche markets. Its activities are centred on three sectors: Chemicals, Upmarket Foods and Life Sciences.